MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies, Inc. Common Stock (TSHA)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Taysha Gene Therapies, Inc. Common Stock
Symbol
TSHA
Shares outstanding
252M shares
Disclosed Ownership
16.9M shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Filing time
06 Aug 2025, 14:13:20 UTC
Date of event
30 Jun 2025
Previous filing
05 Feb 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.7% 16.9M 0 16.7M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 5.6% 14.1M 0 14.1M Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC